Clinical Trial

Diagnostic Performance and Quantitative Analysis of [18F]FET PET in Brain Tumours

Study acronym: FET-BRAIN-DX
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This is a retrospective study encompassing all \[18F\]FET PET scans performed at our centre. By analysing both static and dynamic scans, conducting in-depth kinetic modelling, and comparing quantitative parameters across different tumour types and clinical contexts, the study aims to determine the true diagnostic value of \[18F\]FET PET in everyday clinical practice. The ultimate goal is to identify imaging biomarkers useful for improving tumour characterisation and distinguishing recurrence from post-treatment changes, thereby strengthening the role of \[18F\]FET PET in modern neuro-oncology.
Trial Details
NCT Number NCT07599917
Lead Sponsor IRCCS San Raffaele
Conditions Brain Tumors
Enrollment 69 participants
Start Date 2026-06-01
Primary Completion 2026-09-01 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-05-20